The Lancet Regional Health - Europe : Impact Factor & More
eISSN: 2666-7762pISSN: 2666-7762
Open AccessShare this on:
Key Metrics
CiteScore 
5
Scite Index
0.87 5-Year SI
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on The Lancet Regional Health - Europe
The Lancet Regional Health - Europe Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | USD 4000 |
| Publication Time | 9 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in The Lancet Regional Health - Europe ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in The Lancet Regional Health - Europe
Infectious diseases burden of health system collapse in Gaza and Lebanon: a call for action
- 1 Oct 2026
- The Lancet Regional Health - Europe
Outcomes, prognostic factors, and the role of intracranial pressure monitoring in severe community-acquired bacterial meningitis: a multicenter retrospective cohort study.
- 1 Sep 2026
- The Lancet regional health. Europe
Rebalancing innovation, affordability, and access for orphan drugs in the European Union.
- 1 Sep 2026
- The Lancet regional health. Europe
Whole genome sequencing in cerebral palsy: a UK paediatric pilot study.
- 1 Sep 2026
- The Lancet regional health. Europe
Endolymphatic duct blockage for Ménière's disease: a double-blind, randomised controlled trial.
- 1 Sep 2026
- The Lancet regional health. Europe
Prolonged CD38 targeting with felzartamab in antibody-mediated kidney transplant rejection: a biomarker-guided open-label phase 2 extension.
- 1 Sep 2026
- The Lancet regional health. Europe
Infectious diseases burden of health system collapse in Gaza and Lebanon: a call for action
- 1 Oct 2026
- The Lancet Regional Health - Europe
Outcomes, prognostic factors, and the role of intracranial pressure monitoring in severe community-acquired bacterial meningitis: a multicenter retrospective cohort study.
- 1 Sep 2026
- The Lancet regional health. Europe
Rebalancing innovation, affordability, and access for orphan drugs in the European Union.
- 1 Sep 2026
- The Lancet regional health. Europe
Whole genome sequencing in cerebral palsy: a UK paediatric pilot study.
- 1 Sep 2026
- The Lancet regional health. Europe
Endolymphatic duct blockage for Ménière's disease: a double-blind, randomised controlled trial.
- 1 Sep 2026
- The Lancet regional health. Europe
Prolonged CD38 targeting with felzartamab in antibody-mediated kidney transplant rejection: a biomarker-guided open-label phase 2 extension.
- 1 Sep 2026
- The Lancet regional health. Europe
FAQs on The Lancet Regional Health - Europe
What is the publishing frequency of The Lancet Regional Health - Europe? 
How many articles did The Lancet Regional Health - Europe publish last year?
What is the eISSN & pISSN for The Lancet Regional Health - Europe?
What is Citescore for The Lancet Regional Health - Europe?
Who is the publisher of The Lancet Regional Health - Europe?
